Brief: VYNE Reports Positive Preclinical Data For Lead BET Inhibitor, VYN201, In Human Skin Model Of Vitiligo

YARROW BIOSCIENCE

07/03/2022 12:41

March 7 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE REPORTS POSITIVE PRECLINICAL DATA FOR LEAD BET
INHIBITOR,
VYN201, IN HUMAN SKIN MODEL OF VITILIGO

Source text for Eikon:  ID:nGNX3t6J7w 
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))